Table 6.
Alive (n = 21) | Dead (n = 22) | p Value | Univariate HR (95%CI) | |
---|---|---|---|---|
Age (years) | 76 (±15.1) | 84.4 (±6.3) | 0.035 | 1.1 (1–1.1) |
LVEF ≤ 40% | 1 (4.8) | 7 (31.8) | 0.047 | 1.97 (1.2–3.2) |
AF or flutter | 7 (33.3) | 15 (68.2) | 0.022 | 2.1 (1.1–4) |
CKD | 5 (23.8) | 15 (59.1) | 0.019 | 2 (1.1–3.6) |
NT-proBNP *, pg/mL | 747 (182–1773) | 10,966 (4539–16,094) | 0.003 | 1.065 † (1.02–1.11) |
NT-proBNP * ≥ 2598 pg/mL | 3 (20) | 11 (91.7) | 0.001 | 10.2 (1.5–68.5) |
Hs-TnT * < 14 ng/L | 5 (27.8) | 0 (0) | 0.052 | 0.48 (0.33–0.71) |
NYHA ≥ III (advanced HF) | 4 (19) | 4 (18.1) | 0.522 | - |
Women | 10 (47.6) | 12 (54.5) | 0.65 | - |
Smoking | 3 (14.3) | 6 (27.2) | 0.231 | - |
DM | 8 (38.1) | 13 (59.1) | 0.169 | - |
Hypertension | 19 (90.5) | 19 (86.4) | 1 | - |
Dyslipemia | 11 (52.4) | 16 (72.7) | 0.168 | - |
Results are expressed as mean and (standard deviation), or number and (percentage). HR: Hazard Ratio. CI: Confidence Interval. DM: Diabetes mellitus. LVEF: Left ventricle ejection fraction. NYHA: New York Heart Association Functional Class. HF: Heart Failure. AF: Atrial fibrillation. CKD: Chronic kidney disease. NT-proBNP, N-terminal probrain natriuretic peptide. Hs-TnT: high-sensitivity troponin-T. * only for patients with biomarkers on admission. † NT-proBNP, per 1000 pg/mL.